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Aim: To investigate the short-term effect of ileal interposition (IT) surgery on gut morphology and
enteroendocrine cell numbers in the pre-diabetic UC Davis type 2 diabetes mellitus (UCD-T2DM) rat.
Study design: Two-month oldmaleUCD-T2DMrats underwent either sham (n=5) or IT (n=5) surgery. Intestines
were collected 1.5 months after surgery. The jejunum, ileum and colon regions were processed for histochemical
and immunohistochemical labeling and stereological analyses of changes in gut morphometry and number of
enteroendocrine cells.
Results: Stereological analysis showed that intestinal volume, luminal surface area and the number of all
chromogranin A-positive enteroendocrine cells were markedly increased in the IT rats compared with sham-
operated animals. Subanalyses of the glucagon-like peptide 2, cholecystokinin, serotonin cells and the neurotensin
immunoreactive sub-pool of enteroendocrine cells in the IT region revealed an increase in numbers across pheno-
types. However, the density of the different cell types varied.
Conclusion: IT surgery in the UCD-T2DM rat leads to rapid alterations in gut morphometry and an increase in the
number of enteroendocrine cells. This effect may potentially explain why IT surgery delays the onset of type 2
diabetes in the UCD-T2DM rat.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Themarked effect of bariatric surgery and gut resection on intestinal
morphology has been a matter of intense investigation for more than
half a century [1,2]. The numerous intestinal adaptations include signif-
icant alterations in crypt cell proliferation, lengthening of the villi,
increases in the crypts-to-villi ratio and an overall increase in themuco-
sal weight [3]. The responsible factors may be diverse. Peptides, growth
factors, cytokines, blood ﬂow and neural inﬂuences have all been
suggested to play important roles in causing these changes in the intes-
tine [4–7].
Recently, much attention has been paid to gastrointestinal (GI)
peptides such as glucagon-like-peptide-2 (GLP-2) which function as a
trophic gut hormone [8,9]. The intestinotrophic effects of GLP-2 have
led to the development and recent approval of a GLP-2 analog for the
treatment of short bowel syndrome [10,11]. GLP-2 is co-secreted with
both GLP-1 and oxyntomodulin from the processing of proglucagon in
the intestinal L-cells [12,13] distributed throughout the intestinal1, 2970 Hørsholm, Denmark.
ghts reserved.tracts with the highest numerical density being in the distal ileum
[14,15]. In addition to proglucagon, L-cells are also known to express
peptide tyrosine tyrosine (PYY) which leads to a marked inhibition of
food intake in rodents and man [16,17]. Recently, we demonstrated
that Roux-en-Y gastric bypass (RYGB) in Wistar rats is coupled with
an increased number of intestinal L-cells, as well as increased
preproglucagon and PYYmRNA expression, thereby providing a plausi-
ble explanation for the powerful effect of this kind of surgery on body
weight and resolution of type 2 diabetes [18]. Elevated post-prandial
levels of GLP-1 and PYY are also a general trait of ileal interposition
(IT) surgery [19] with associated effects on glucose homeostasis
[19–22]. However, relatively little is known about this kind of surgery
on endocrine cell numbers.
Due to their important clinical application for the treatment of type
2 diabetes and potentially also body weight [23,24] L-cell derived
peptides has received increased focus. However, a number of other
enteroendocrine (EEC) cell types have important roles in digestive
physiology and obesity related diseases (for review, see [25]). It is
therefore of potential importance to understand the quantitative and
qualitative alterations in those cell types as well to facilitate our under-
standing of the metabolic beneﬁts and the implications of bariatric
surgery. EECs have traditionally been divided into different subtypes
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phenotype may vary, they also share a number of common morpholog-
ical characteristics. This includes the presence of secretary vesicles,
components of which can be exploited as general marker for EECs [28].
Double immunohistochemistry against chromogranin A, a matrix-
soluble glycoprotein commonly found in secretary vesicles [28], and a
number of different peptidergic hormones have demonstrated that
chromogranin A co-localizes not only with serotonin (5-HT positive
cells), but alsowith cholecystokinin, neurotensin and PYY/GLP-1 positive
L-cells in the GI tract, thereby supporting the use of chromogranin A as a
general marker for EECs [29].
In this study we aimed to examine changes in intestinal volume,
intestinal surface area and the total number of chromogranin A immu-
noreactive EECs, as well as speciﬁc subtypes, following IT surgery in
the pre-diabetic UCD-T2DM rat model [30,31]. In this animal model, IT
surgery has been shown to improve glucose and lipid metabolism and
delay the onset of diabetes potentially associated with increased
GLP-1 and PYY secretion, increased circulating bile acid concentrations,
decreased endoplasmatic reticulum (ER) stress signaling and improved
beta-cell function [31].
However, the effect of IT surgery on gut morphology and EEC
numbers has not previously been assessed using stereological methods.
2. Materials and methods
2.1. Animals
The present study is based on tissues from a published in vivo study
[31].Animals were housed individually in hanging wire cages in the an-
imal facility at the Department of Nutrition at the University of Califor-
nia, Davis (UCD), USA andmaintained on a 14:10-hour light–dark cycle.
At two months of age rats underwent sham (n= 5) or IT surgery (n=
5) and were terminated 1.5 months later for tissue collection. All ani-
mals received ground chow (no. 5012; Ralston Purina, Belmont, CA,
USA). Food intake and body weight were recorded three times a week.
Diabetes onset was monitored by measuring non-fasting blood glucose
weekly with a glucose meter (One-Touch Ultra, LifeScan, Milpitas, CA,
USA) at 14:00–16:00 h. Diabetes onset was deﬁned as a non-fasted
blood glucose value above 11.1 mmol/l (200 mg/dl) for two consecu-
tive weeks. The experimental protocols were approved by the Universi-
ty of California Davis Institutional Animal Care and Use Committee.
2.2. Oral glucose tolerance test
An oral glucose tolerance test (OGTT) was performed in all animals
at 1 month after surgery. Animals were fasted overnight (12 h) and
then received a 50% dextrose solution (1 g/kg BW) by oral gavage.
Blood was collected from the tail for measurement of glucose and
insulin concentrations. A second aliquot of blood was placed in tubes
containing ethylenediaminetetraacetic acid (EDTA), aprotinin and a
dipeptidyl peptidase-4 inhibitor and analyzed for total GLP-1 and active
GLP-1.
2.3. Hormone and metabolite measurements
Fasting (13 h) EDTA plasma and whole blood samples were col-
lected at baseline and on the day of euthanasia. Plasma was assayed
for glucose using enzymatic colorimetric assays (Thermo DMA) and
insulin using ELISA (Millipore). Total GLP-1 was measured by sand-
wich electrochemiluminescence immunoassay (Meso Scale Discov-
ery). HbA1cwas measured using an enzymatic colorimetric assay
(Diazyme; Poway, CA, USA). Serum glucose was measured using an
enzymatic colorimetric assay for glucose (Thermo DMA Louisville,
CO, USA). Insulin and total GLP-1 were measured by sandwich
electrochemiluminescence immunoassay (Meso Scale Discovery;Gaithersburg, MA, USA). Plasma GLP-17-36 was measured by ro-
dent/rat speciﬁc ELISAs (Millipore, St. Charles, MO, USA).
2.4. IT surgery
IT surgery was performed according to the procedure described by
Koopmans and Sclafani [20]. Rats were placed on a liquid diet (Boost;
Novartis, Minneapolis, MN, USA) for 4 days prior to surgery and
7 days post-surgery and received enroﬂoxacin (20 mg/kg subcutane-
ously) before and after surgery. Anesthesiawas induced andmaintained
with isoﬂurane (2%–5%). A midline abdominal incision was made and a
10-cm segment of ileum 5–10 cm proximal to the ileocaecal valve was
isolated and transected. An anastomosiswas formedwith the remaining
ends of the ileum using 7-0 PDS suture (Ethicon®). Next, a transection
was made 5–10 cm distal to the ligament of Treitz and the isolated
ileal segment was inserted isoperistaltically. The transposed segment
remained innervated with its vasculature intact. Sham surgeries were
performed by making transections in the same locations as in the
IT-operated animals.
2.5. Tissue sampling
At termination, the intestinal tractwas removed,ﬁxed by immersion
in 4% phosphate buffered formaldehyde and stored at 5 °C until further
processing. The jejunoileum, deﬁned from the distal end of the duode-
num to the anterior part of the cecum, was carefully dissected and
subdivided into four distinct segments based on surgical scars from
the site of anastomosis (Fig. 1 A). The colon was included as a separate
ﬁfth segment, while the duodenumwas excluded due to tissue damage
during pancreas removal [31]. Each segment was carefully measured,
pinned down and embedded in a 4% agarose gel after which 8–12
biopsies were sampled systematically uniform randomly across each
segment. The agarose slabs were inﬁltrated overnight in parafﬁn,
mounted two and two together in blocks of parafﬁn and eventually cut
into 5 μm thick parafﬁn sections on a Microm HM340E (Thermo
Scientiﬁc, Florida, USA). Sections weremounted individually on separate
object glasses, or pair-wise as two consecutive sections.
2.6. Immunohistochemistry
The current antibody has previously been shown to co-localize
100% with GLP-1 in brainstem preproglucagon expressing neurons
[32]. EECs were identiﬁed by immunohistochemistry using the
following procedure: sections from the IT regionwere deparafﬁnized
in toluene and rehydrated in series of ethanol to water. Sections
were then subjected to antigen retrieval in Tris-EGTA buffer, blocked
for endogenous peroxidase activity and non-speciﬁc binding before
being incubated with the following primary antibodies for 1 h:
Chromogranin A diluted 1:100 (ab45179, AbCam, Cambridge),
neurotensin diluted 1:3200 (ab43836, AbCam, Cambridge), 5-HT
diluted 1:1600 (rabbit polyclonal antibody, Gubra, Denmark), CCK dilut-
ed 1:3200 (rabbit polyclonal antibody, Gubra, Denmark), GLP-2 diluted
1:16,000 (GLP2-12 F21-A7 antibody, Novo Nordisk, Denmark). Sections
were subsequently visualized using Envision (K4007 and K4010, DAKO,
Glostrup, Denmark) and ﬁnally developed using DAB (DAKO, Glostrup,
Denmark) as chromogen. Slideswere counter-stainedwith hematoxylin,
dehydrated, coverslipped with Pertex (Sakura, Copenhagen, Denmark)
and ﬁnally digitalized on an AperioScanscope AT slide scanner (Aperio,
California, USA).
2.7. Stereological estimation of volume
The GI volumes were estimated using newCAST (Visiopharm,
Hørsholm, Denmark) on digital slides. On each section ﬁelds of views
were sampled in a random systematicway using the newCAST software.
The volumes of themucosal layer, aswell as the submucosa/muscularis/
Fig. 1. Tissue sampling and stereological procedures: graphical illustration of the ileal transposition procedure in sham and IT surgery groups. The whole jejunoileum was dissected and
divided into anterior jejunum, IT region, jejunum and distal ileum based on surgical scars (A). Regional and speciﬁc cellular layer volume (i.e. themucosa, submucosa andmuscularis) was
estimated by point counting (B— top left). Surface area was estimated by counting intersections between line probes and themucosal surface (B— top right), and number was estimated
using the physical dissector on two paired neighbor sections (B bottom panel). Arrow indicates the counting event where an immunoreactive cell is evident in one section and not the
other.
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(Fig. 1B). The number of points hitting the structure of interest was
converted into volume using the principle of Cavalieri:
Volref ¼
X
p  A pð Þ  t
where∑p is the total number of points hitting the structure of interest,
A(p) is the area associated with each grid point and t was the distance
between sections [33].
A shrinkage coefﬁcient was used to convert processed shrunken
tissue into the total original volume and surface area. In-section shrink-
age induced by dehydration and parafﬁn embedding was estimated by
comparing point counts performed on frozen unshrunken sections
with parafﬁn-embedded sections. Shrinkage along the longitudinalaxis was estimated by subjecting 20 mm long agarose embedded
segments to dehydration before re-measuring the length.
2.8. Stereological estimation of intraluminal surface area
The intraluminal surface density and area were estimated by
counting intersections between linear probes and the luminal side of
the gut [34] (Fig. 1B). Surface density (Sv)was estimatedby the relation-
ship between intersection and point counts using the formula:
Sv ¼
2 
X
I
Ip 
X
P
where∑I was the number of intersections of the test lines with the
epithelium of the tunica mucosa, Ip was the test line length associated
34 C.F. Hansen et al. / Regulatory Peptides 189 (2014) 31–39with a point of the grid and∑P was the number of test points hitting
the reference volume. Finally, the absolute surface area was estimated
by multiplying the surface density with the reference volume using
the formula:
S ¼ Sv  Volref
A linear shrinkage factor was assessed to correct surface shrinkage
[35].
2.9. Estimation of the total number of enteroendocrine cells
The total number of immunoreactive cells in the IT region (see Fig. 1)
was estimated using the principle of the physical dissector [34,36]. For
this purpose tissue sections were sampled as two consecutive 5 μm
sections, thus obtaining two adjacent sections on one slide. The slides
were processed for immunoreactivity, digitized and ﬁnally analyzed
on a computer running newCAST software at × 20 magniﬁcation. The
total number of stained cells in a deﬁned sampling volumewas counted
and the particle density Nv was calculated as:
Nv ¼
X
Q
a frameð Þ  h 
X
P
where∑Q is the total number of uniquely counted cells, a(frame) was
the area of the counting frame, h was the distance between the two
sections, and∑P was the total number of points hitting the reference
space. The total number of EECs was ﬁnally determined by multiplying
Nv with the total reference volume.
2.10. Statistics and data presentation
Results are presented as mean ± standard error of mean (SEM)
unless otherwise stated. Statistical signiﬁcance was tested using
unpaired students t-test or one-way ANOVA with Tukey's post-hoc
test. P b 0.05 was considered statistically signiﬁcant. All statistics and
graphs were performed using GraphPad Prism (California, USA).
Illustration and micrographs were created using Adobe Illustrator and
Photoshop software.
3. Results
3.1. Body weight and hormone levels
A detailed description of the in vivo data has been published previ-
ously [31]. These data showed no signiﬁcant change in either food
intake or bodyweight throughout the 1.5 month duration of this study
(Table 1). HbA1c levels were unchanged 1.5 months following IT
surgery, and only minor improvements were noted in terminal fasting
plasma glucose (Table 1). Hence, no animals developed frank diabetes
during the post-surgical period. Fasting insulin levels were signiﬁcantly
lower in the IT group (Table 1) compared to the sham-operated animalsTable 1
Body weight and plasma parameters: all measurements were obtained 1.5 month post-
surgery, except GLP-1 measurements obtained at t = 15 min following OGTT one
month post-surgery. In detail description of the vivo data is previously published [31]. All
values are presented as mean ± SEM. Statistical analysis: One-way ANOVA with Tukey's
multiple comparison post-hoc test, (*Sham/IT vs. Presurgery; ^Sham vs. IT; p b 0.05 for
signiﬁcance).
Presurgery Sham IT
Terminal body weight 383 ± 6.6 560 ± 14.9 536 ± 6.9
Fasting blood glucose (mmol/L) 5.5 ± 0.18 6.6 ± 0.21⁎^ 5.7 ± 0.06
HbA1c (%) 4.0 ± 0.16 4.4 ± 0.20 3.8 ± 0.13
Fasting insulin (ng/ml) 0.95 ± 0.12 3.4 ± 0.34⁎^ 1.7 ± 0.23
Total GLP-1OGTTt = 15′ (pg/ml) N.A. 17.6 ± 4.2^ 73.2 ± 7.5
Active GLP-1OGTTt = 15′ (pg/ml) N.A. 4.2 ± 0.5^ 6.7 ± 0.6whereas active and total OGTT GLP-1 plasma levels were signiﬁcantly
increased 1.5 months post-surgery (Table 1).3.2. Gut volume and surface area
The length of the intestinal regions did not differ between groups
(Table 2). Stereological quantiﬁcation of total and regional gut volumes
revealed a signiﬁcant increase in the Jejunum and Distal ileum in the IT-
operated rats comparedwith the sham group (Fig. 2A–B)whichwas re-
lated to a signiﬁcant increase in both mucosa (Fig. 2C), and submucosa/
muscularis/serosa volume (Fig. 2D). The greatest mean increase in mu-
cosa volume was observed in the transposed IT segment, which was al-
most 70% enlarged compared with that in sham animals (P b 0.05)
(Fig. 2C). No signiﬁcant changes (P N 0.05) were observed in the colon
(SHAM 1.76 ± 0.15 vs. IT 2.05 ± 0.13 cm3). The increased mucosal vol-
ume was associated with a similar increase in mucosal surface area,
reaching statistical signiﬁcance in the IT region (Fig. 2E), and with no
signiﬁcant changes in the colon (SHAM 89.20 ± 9.93 vs. IT 95.80 ±
7.52 cm3).3.3. Number and density of enteroendocrine cells
Chromogranin A immunoreactive cells were distributed across the
entire mucosa in both sham and IT surgery groups (Fig. 3A). A similar
distribution pattern was observed for CCK and 5-HT positive cells. In
contrast, GLP-2 positive cells were restricted primarily to the crypts
and basal part of the villi while neurotensin positive cells were located
mainly in the apical parts of the villi. In line with the increased mucosal
volume, the total population of enteroendocrine chromogranin A im-
munoreactive cells quantiﬁed stereologically was markedly increased
in the IT region compared to shamanimals (Fig. 3B) fromapproximately
2.2 million cells to 3.5 million. In contrast, chromogranin A immunore-
active cell density was signiﬁcantly reduced by approximately 20% in
the IT group compared with sham (Fig. 3C). Immunohistochemical
staining for CKK, GLP-2, 5-HT and neurotensin in the IT region
(Fig. 4A–D) showed that all four enteroendocrine cell subtypes were
to be markedly increased in number in the IT region, most noticeably
the CCK and GLP-2 immunoreactive cells, respectively (Fig. 4E). The
density of CCK and GLP-2 immunoreactive cells did not differ between
IT and sham groups, but both neurotensin and 5-HT cell density were
reduced in the IT rats (Fig. 4F).4. Discussion
The present study aimed to investigate the short-term effect of IT
surgery on intestinal morphology and EEC numbers in pre-diabetic
UCD-T2DM rats. Using mathematically unbiased stereological methods
we report that IT surgery led to a marked increase in volume and
intraluminal surface area in the transposed and adjacent distal region
of the ileum, which was coupled to an increased number of EECs. The
increase in the total number of EECs, as well as in individual counts of
GLP-2, CCK, 5-HT and neurotensin immunoreactive cell types, is consid-
ered a fundamental cause of the increased circulating gut hormones
observed after IT surgery and the powerful effect of this kind of surgery
on obesity-associated diseases, like type-2-diabetes.Table 2
Intestinal length: length of segments at termination 1.5 months post-surgery.
Length (cm) Sham IT
Anterior gut 6.8 ± 2.7 10.6 ± 5.5
IT 21.5 ± 5.0 21.4 ± 1.3
Jejunum 45.9 ± 8.0 50.9 ± 6.0
Distal ileum 10.8 ± 3.8 8.9 ± 1.0
Total jejunoileum 85.0 ± 7.4 91.8 ± 6.1
Fig. 2.Gut volume and surface area: representative images from both groups showing evident hypertrophy in the transposed region of IT animals compared with SHAM (A). Estimates of
total regional volume (B), total regional mucosa volume (C), and total submucosa/muscularis/serosa volume (D). Total luminal surface area (E) (*p b 0.05 for signiﬁcance).
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analysis of EEC populations after IT surgery in a rodent model of type
2 diabetes. Stereological methods have previously been shown to be
superior to traditional morphometric analysis using planar measure-
ments of villus length [37] and is distinguished by producing absolute
values of intestinal volume, surface area and the number of cells instead
of ratios, thereby allowing for a better comparison between studies. Our
estimates of total volume and surface area in the sham group are in line
with previous ﬁndings from other experiments in laboratory rats
[38–41].
Previous studies have looked into the effects of IT surgery on gut
morphology and speciﬁc EEC dynamics using conventional methods.
The ﬁndings were coupled with changes in hormonal gene expression
patterns aswell as hormonal plasma levels in rodents [1,21,42–50]. Col-
lectively, these data conﬁrmed that IT surgery leads to considerable
changes in the gut. Gut hypertrophy and cellular hyperplasia as wellas increased gut hormone gene expression and secretion are now
well-known characteristics of several gastrointestinal surgical interven-
tions, including gut resection and other types of bariatric surgery
[18,51–56]. These morphological changes have been suggested to
develop as compensatory mechanisms to overcome the reduced
absorptive capacity [57] of the intestine. However, in the IT surgical
model there is no change in gut length, nutrient absorption or food
intake, suggesting that a different factor is leading to the post-
operative morphological changes. In this respect, GLP-2 may be of
speciﬁc interest since GLP-2 signaling increases intestinal growth by
enhancing crypt cell proliferation and inhibiting apoptosis [8,9]. Like
GLP-1, plasma GLP-2 is known to be highly increased in IT surgical
models [50,58], and known to affect gut morphology following exoge-
nous treatment [51,55]. Moreover, alterations in food composition and
thus changes in macronutrients or bile acid concentrations may affect
L-cell derived hormone release. Detection of nutrients by distal
Fig. 3. Enteroendocrine cell number and density. Images from the IT region in SHAM and IT surgery groups stained for chromogranin A (A). Total number of cells (B) and density (C) of
enteroendocrine chromogranin A immunoreactive cells in the IT transposed region (*p b 0.05 for signiﬁcance).
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Similarly, bile acid stimulation of the TGR5 receptor located on GLP-1
secreting cells [30,42] also affects hormone release [60,61].
The primary objective of this study was to evaluate changes in the
total number of EECs in the IT region on the basis of chromogranin A
immunoreactivity. In contrast to our previous studies focusing speciﬁ-
cally on L-cell number and density in RYGB and Zucker Diabetic Fatty
(ZDF) rats [15,18], we observed an unexpected change in overall EEC
density in the IT region. This observation led us to further examine a
number of endocrine cellular subtypes based on their hormonal
content. The various roles of hormones and peptides released from the
gut coupled with the known, but still not fully elucidated effect of
L-cell derived peptides on food intake, bodyweight and glucose homeo-
stasis, were considered important to better understand the effect of IT
surgery on diabetes prevention in the UCD-T2D rat model. Serotonin
(5-HT), which is produced by the enterochromafﬁn (EC) cells, is already
known to inﬂuence gastrointestinal motility and plays important roles
in food intake and control of body weight [62,63]. Similarly CCK,
which is produced by the intestinal I-cells, is considered a key hormone
in gut signaling of hunger and satiety [64]. Neurotensin, produced by
the intestinal N-cells, is implicated in appetite regulation, stimulation
of pancreatic secretion, inhibition of gastric/small bowel motility and
gastric acid secretion [65]. The physiological implications of these
hormones underscore the importance of gaining additional data on
their numbers and density after IT surgery. To date both CCK and
neurotensin levels have been reported to be increased following bariat-
ric intervention [66,67], whereas relatively little is known about the
regulation of serotonin [68].
Our quantitative analyses demonstrated a signiﬁcantly increased
number of all ECC subtypes in the IT region. The density of GLP-2 andCCK immunoreactive cells was unchanged between IT and sham-
operated rats, but the density of neurotensin and 5-HT immunoreactive
cells was signiﬁcantly reduced. Despite corroborating our previous ﬁnd-
ings on L-cell hyperplasia in ZDF andRYGB ratmodels [15,18] these data
somewhat contradict our earlier hypothesis that allendocrine cells,
which differentiate from a common pluripotent stem cell in the crypt
of the intestine [69–72], are genetically encoded in the mucosal
turnover and are directly correlated to changes in intestinal volume.
The current data suggest thatmore complicated regulatorymechanisms
are involved thanmucosal hypertrophy alone. One should note that the
sum of the four cell subtypes surpasses the total number of ECCs. This
discrepancy may be related to differences in the antigenicity of the
antibodies, but it may conversely also imply that the individual cells
are able to express more than one hormone. GLP-1, GIP (K-cells) and
CCK-positive cells have previously been shown to overlap in the upper
intestine [73,74], whereas PYY, GLP-1, CCK, and neurotensin are
known to be co-expressed in the same cells in the distal gut [75,76].
This challenges the traditional classiﬁcation of endocrine cell types
based on their hormonal content [77] and may explain the changes in
cell density. Moreover, since the endocrine cells differentiate as they
migrate towards the tips of the villi before they eventually undergo
apoptosis and are extruded into the lumen [71,76,78], this may also
explain the reduced density of the more apically located 5-HT and
neurotensin-labeled cells. The density of neurotensin-labeled cells is
also signiﬁcantly reduced in rats following RYGB, whereas the densities
of GLP-1, CCK and 5-HT are not [54]. There is presently no adequate
explanation for the discrepancy between Mumphrey's data showing
no changes in the density of 5-HT, and our data showing a decrease,
but it may be related to the differentmodels used, the different segment
analyses and importantly the different methodology.
Fig. 4. Enteroendocrine cell subtypes. Images from the IT region stained for GLP-2 (A), CCK (B), 5-HT (C) and neurotensin (D) immunoreactivity. The total number (E) and density (F) of CCK,
GLP-2, neurotensin and 5-HT cells in the IT transposed region (*p b 0.05 for signiﬁcance).
37C.F. Hansen et al. / Regulatory Peptides 189 (2014) 31–39In the present study the trophic effects on the gutwasmost predom-
inant in the transposed region, with less effects in the remaining
jejunum. The same pattern was observed by Thulesen et al. [58] exam-
ining differences in tissue GLP-2 and plasma GLP-2 levels following
ileal–jejunal transposition surgery. GLP-2 is thought to have both endo-
crine and paracrine effects [79]. Thus the indirect paracrine effect of
GLP-2 could potentially explain the greater trophic effect observed in
the hyperstimulated transposed region. Collectively, our study conﬁrms
and extends the reports of gut hypertrophy and EEC hyperplasia after
various types of gut surgeries.
In summary, the current study demonstrates that IT surgery leads to
a rapid intestinal hypertrophy that is independent of body weight anddiabetic state. The marked hypertrophy is coupled with a signiﬁcant
increase in the total number of ECCs in the transposed region potentially
contributing to an increased post-prandial hormonal secretory capacity
and the marked effect of IT surgery on diabetes prevention in the
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